Safety and efficacy of olesoxime in patients with type 2 or non-ambulatory type 3 spinal muscular atrophy: a randomised, double-blind, placebo-controlled phase 2 trial. (Q34556098)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Safety and efficacy of olesoxime in patients with type 2 or non-ambulatory type 3 spinal muscular atrophy: a randomised, double-blind, placebo-controlled phase 2 trial. |
scientific article |
Statements
Safety and efficacy of olesoxime in patients with type 2 or non-ambulatory type 3 spinal muscular atrophy: a randomised, double-blind, placebo-controlled phase 2 trial (English)
Anna Lusakowska
Francesco Muntoni
Carol Reid
Giacomo P Comi
Jean-Marie Cuisset
Jean-Louis Abitbol
Bruno Scherrer
Patricia Sanwald Ducray
Jeppe Buchbjerg
Eduardo Vianna
W Ludo van der Pol
Carole Vuillerot
Thomas Blaettler
Paulo Fontoura
Olesoxime SMA Phase 2 Study Investigators